|
09.03.2015 17:35:15
|
Actelion to host an investor event at American College of Cardiology (ACC.15)
Actelion Pharmaceuticals Ltd / Actelion to host an investor event at American College of Cardiology (ACC.15) . Processed and transmitted by Nasdaq OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Dear member of the investment community
Following the presentation 'Effect of selexipag on morbidity/mortality in pulmonary arterial hypertension: results of the GRIPHON study' by Vallerie V. McLaughlin on March 15, 2015 at 12:00 p.m. PDT, Actelion will host an investor event at American College of Cardiology (ACC.15).
This event is by invitation only for covering buy- and sell-side analysts as well as institutional investors.
If you wish to attend, please contact: investor.relations@actelion.com
Meeting Information
15 March 2015
6.00 - 8.30 p.m. Pacific Daylight Time
Venue
Hard Rock Hotel
207 5th Avenue
San Diego, CA 92101
Highlights
Oral presentation entitled 'Effect of selexipag on morbidity/mortality in pulmonary arterial hypertension: results of the GRIPHON study'.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Globenewswire
--- End of Message ---
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Switzerland
ISIN: CH0010532478;
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Actelion Ltd.mehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Actelion Ltd.mehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.